Timing of last chemotherapy and the end of life in patients (pts) with metastatic cancer.

被引：0
|
作者：
Brollo, Marianna
Bratta, Massimo
Molinaro, Simona
Diana, Giannarelli
Ricci, Mariannina
Bassanelli, Maria
Ceribelli, Anna
机构：
[1] San Camillo De Lellis Hosp, Rieti, Italy
[2] ASL Rieti, Rieti, Italy
[3] Regina Elena Inst Canc Res, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 34期
关键词：
D O I：
10.1200/JCO.2018.36.34_suppl.59
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
59
引用
收藏
页数：2
相关论文
共 50 条
  • [41] End of life treatment of metastatic lung cancer patients in the Netherlands
    Douma, Gea
    Fransen, Heidi P.
    Venmans, Ben J. W.
    Aarts, Mieke J.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [42] Intermediate end point for survival for patients with hormone refractory metastatic prostate cancer.
    D'Amico, AV
    Chen, MH
    Cox, MC
    Dahut, W
    Figg, WD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 391S - 391S
  • [43] Chemotherapy and Tyrosine Kinase Inhibitors in the last month of life in patients with metastatic lung cancer: A patient file study in the Netherlands
    Mieras, Adinda
    Becker-Commissaris, Annemarie
    Pasman, H. Roeline W.
    Dingemans, Anne-Marie M. C.
    Kok, Edith, V
    Cornelissen, Robin
    Jacobs, Wouter
    van den Berg, Jan Willem
    Welling, Alle
    Bogaarts, Brigitte A. H. A.
    Pronk, Lemke
    Onwuteaka-Philipsen, Bregje D.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2020, 29 (02)
  • [44] Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US
    Kerekes, Daniel M.
    Frey, Alexander E.
    Prsic, Elizabeth H.
    Tran, Thuy T.
    Clune, James E.
    Sznol, Mario
    Kluger, Harriet M.
    Forman, Howard P.
    Becher, Robert D.
    Olino, Kelly L.
    Khan, Sajid A.
    [J]. LANCET ONCOLOGY, 2024, 25 (02): : 147 - 147
  • [45] Chemotherapy use during the last 30 days of life in patients with cancer
    Rodriguez, Maria Alma
    DeJesus, Yvette
    Cheng, Lee
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
  • [46] The effect of chemotherapy on survival applied in the last term of life in cancer patients
    Isik, U.
    Erol, A.
    Cakmak, Y.
    Ozden, E.
    Kefeli, U.
    Cabuk, D.
    Uygun, K.
    Simsek, M.
    [J]. LEUKEMIA RESEARCH, 2019, 85 : S36 - S36
  • [47] Transcriptomic heterogeneity of metastatic disease timing within metastatic castrationsensitive prostate cancer.
    Sutera, Philip
    Shetty, Amol
    Hakansson, Alexander K.
    Van der Eecken, Kim
    Song, Yang
    Liu, Yang
    Fonteyne, Valerie
    Verbeke, Sofie
    Song, Daniel Y.
    Ross, Ashley
    Feng, Felix Y.
    Gillessen, Silke
    Attard, Gerhardt
    James, Nicholas D.
    Lotan, Tamara L.
    Davicioni, Elai
    Sweeney, Christopher
    Tran, Phuoc T.
    Deek, Matthew Pierre
    Ost, Piet
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [48] Trends in receiving chemotherapy for advanced cancer patients at the end of life
    Hee Seung Lee
    Kyeong Hyeon Chun
    Dochang Moon
    Hahn Kyu yeon
    Sanghoon Lee
    SooHyeon Lee
    [J]. BMC Palliative Care, 14
  • [49] Chemotherapy and healthcare utilisation near the end of life in patients with cancer
    Schulkes, K. J. G.
    van Walree, I. C.
    van Elden, L. J. R.
    van den Bos, F.
    van Huis-Tanja, L.
    Lammers, J-W J.
    Huinink, D. ten Bokkel
    Hamaker, M. E.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2018, 27 (02)
  • [50] Continuous versus intermittent chemotherapy in metastatic colorectal cancer.
    Alexopoulos, C. G.
    Kotsori, A. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 166S - 166S
12345